Orchestra BioMed Inc.

NASDAQ: OBIO · Real-Time Price · USD
3.32
0.27 (8.85%)
At close: Jun 06, 2025, 3:59 PM
3.31
-0.30%
After-hours: Jun 06, 2025, 04:04 PM EDT

Orchestra BioMed Statistics

Share Statistics

Orchestra BioMed has 38.31M shares outstanding. The number of shares has increased by 6.22% in one year.

38.31M
6.22%
0%
49.81%
n/a
297
0.08%

Short Selling Information

The latest short interest is 1.19M, so 3.12% of the outstanding shares have been sold short.

1.19M
3.12%
6.39%
4.53

Valuation Ratios

The PE ratio is -2.41 and the forward PE ratio is -1.84. Orchestra BioMed's PEG ratio is -0.2.

-2.41
-1.84
55.83
2.1
4.47
-2.9
-0.2
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Orchestra BioMed.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 4.27, with a Debt / Equity ratio of 0.5.

4.27
4.26
0.5
-0.26
-0.33
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$37,685.71
$-871,771.43
70
0.03
1.18

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by -61.83% in the last 52 weeks. The beta is 0.63, so Orchestra BioMed's price volatility has been higher than the market average.

0.63
-61.83%
2.97
4.72
52.98
382,853

Income Statement

In the last 12 months, Orchestra BioMed had revenue of 2.64M and earned -61.02M in profits. Earnings per share was -1.66.

2.64M
2.43M
-64.3M
-61.02M
-64.3M
-64.3M
-1.66
Full Income Statement

Balance Sheet

The company has 22.26M in cash and 16.53M in debt, giving a net cash position of 5.73M.

22.26M
16.53M
5.73M
-309.88M
59.05M
36.41M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -50.56M and capital expenditures -289K, giving a free cash flow of -50.85M.

-50.56M
-289K
-50.85M
-1.38
Full Cash Flow Statement

Margins

Gross margin is 92.27%, with operating and profit margins of -2437.49% and -2313.27%.

92.27%
-2437.49%
-2313.27%
-2313.27%
-2437.49%
-2437.49%
-1927.48%

Dividends & Yields

OBIO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for OBIO is $12, which is 293.4% higher than the current price. The consensus rating is "Buy".

$12
293.4%
Buy
5
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

-9.31
3